I carry out research mainly in the field of genetics and pharmacogenetics in psychiatry and I started working in this field when I was a medical student, to help identify markers that could lead treatments more targeted on the individual profile. I have followed this path in the following years and within the framework of the phd, obtained from Maastricht University in 2018, as well as in years spent working as postdoc at King's College London university In 2021, I became a research fellow at the University of Bologna and then associate professor in 2024, continuing to work mainly on possible markers to personalize psychopharmacological therapies, in line with the MNESYS, Spoke 5 Mood and Psychosis project.
In addition to genetic variants as predictors of drug effects, I have worked on other biomarkers and clinical profiling of patients, with particular attention to mood and psychotic disorders. Such disorders are a heterogeneous group, therefore the identification of clinical patterns of symptoms related to the effects of the treatment and their correlation with specific underlying biological mechanisms are key objectives, in order to enable a prescription and
monitoring that is as personalized as possible, combining biological but also clinical markers. These themes are central within the MNESYS, Spoke 5 Mood and Psychosis project.
